Antibiotic resistance in exopolysaccharide-forming Staphylococcus epidermidis clinical isolates from orthopaedic

Carla Renata Arciola1, Davide Campoccia, Simonetta Gamberini

  • 1Research Unit on Implant Infections, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy. carlarenata.arciola@ior.it

Biomaterials
|June 14, 2005
PubMed

Insights

Staphylococcus epidermidis causes implant infections and shows increasing antibiotic resistance. Exopolysaccharide production in these bacteria is linked to higher resistance to several antibiotics, including aminoglycosides and ciprofloxacin.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Staphylococcus epidermidis is an opportunistic pathogen frequently causing implant-associated infections.
  • This pathogen is known for its ability to form biofilms and exhibits growing antimicrobial drug resistance.
  • Orthopaedic implant infections pose a significant clinical challenge due to treatment difficulties.

Purpose of the Study:

  • To investigate the antibiotic resistance patterns of clinical Staphylococcus epidermidis strains isolated from orthopaedic implant infections.
  • To determine the prevalence of resistance to 16 different antibiotics.
  • To explore the association between exopolysaccharide (EPS) production, relevant to biofilm formation, and antibiotic resistance in S. epidermidis.

Main Methods:

  • Phenotypic and genotypic characterization of 342 clinical S. epidermidis isolates from orthopaedic implant infections.
  • Testing of isolate susceptibility to a panel of 16 different antibiotics.
  • Assessment of exopolysaccharide production to evaluate its link with antibiotic resistance.

Main Results:

  • Approximately 10% of isolates were sensitive to all tested antibiotics.
  • High resistance rates were observed for penicillin, ampicillin, cefazolin, and cefamandole (over 80%).
  • Exopolysaccharide-producing strains showed significantly higher resistance to aminoglycosides, sulfamethoxazole, and ciprofloxacin, and were more prone to multidrug resistance.

Conclusions:

  • Staphylococcus epidermidis strains from orthopaedic implant infections display significant antimicrobial resistance, particularly to beta-lactams.
  • Exopolysaccharide production is associated with increased antibiotic resistance in S. epidermidis, highlighting its role in treatment failure.
  • Understanding these resistance mechanisms is crucial for managing implant-associated infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...